← All indications
DNA Repair-Deficiency Disorders
Disorders resulting from defective DNA REPAIR processes or the associated cellular responses to DNA DAMAGE.
Subtype terms (11)
More specific conditions that are subtypes of DNA Repair-Deficiency Disorders in the MeSH hierarchy.
- Ataxia Telangiectasia
31 drugs (28 approved, 3 experimental)
- Bloom Syndrome
- Cockayne Syndrome
1 drug approved
- Colorectal Neoplasms, Hereditary Nonpolyposis
24 drugs (19 approved, 5 experimental)
- Fanconi Anemia
49 drugs (28 approved, 21 experimental)
- Li-Fraumeni Syndrome
2 drugs approved
- Nijmegen Breakage Syndrome
1 drug approved
- Rothmund-Thomson Syndrome
- Severe Combined Immunodeficiency
42 drugs (27 approved, 15 experimental)
- Werner Syndrome
2 drugs (1 approved, 1 experimental)
- Xeroderma Pigmentosum
3 drugs approved
Drugs by status
Phase 4 trials (1)
Phase 3 trials (4)
Phase 2 trials (12)
Phase 1 trials (5)
Other trials (1)
Organizations
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (1)